News

Ophthalmic medical technology company Glaukos Corporation committed to the development of world-class products aiming to revolutionise the treatment of Glaucoma declared that it has…
Read More...

ANI Pharmaceuticals announced that it has acquired the NDAs and U.S. rights to market ATACAND, ATACAND HCT, ARIMIDEX, and CASODEX from AstraZeneca for $46.5 million in cash, royalties,…
Read More...

HyLeukin is an immuno-oncology agent comprised of an optimally engineered Interleukin-7 (IL-7) molecule based on Genexine's proprietary long-acting platform technology. Genexine…
Read More...

Mallinckrodt announced that they have entered into an agreement under which Mallinckrodt will acquire Sucampo, including its commercial and development assets. The transaction was…
Read More...

Teva Pharmaceutical Industries Ltd., announced the exclusive launch of a generic version of Reyataz®1 (atazanavir) capsules in the U.S. Atazanavir sulfate capsules are a protease…
Read More...

Soligenix announced that the United States (US) Patent Office has granted the patent entitled "Novel Peptides and Analogs for Use in the Treatment of Oral Mucositis."  The newly issued…
Read More...

Recipharm AB (publ) announces that it has reached an agreement to acquire the remaining 26 per cent of the shares of Nitin Lifesciences Limited which were owned by members of the…
Read More...

Roche and Ignyta announced they have entered into a definitive merger agreement for Roche to fully acquire Ignyta at a price of US$ 27.00 per share in an all-cash transaction. This…
Read More...

Nanobiotix SA Announces that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) Application for NBTXR3, a first-in-class nanoparticle designed…
Read More...

Confo Therapeutics announced that it has entered into a research collaboration and license agreement with Roche for the discovery, development and commercialisation of novel, small…
Read More...

DiCE Molecules announced a multi-year collaboration to discover new small molecules against multiple targets of interest to Genentech. The collaboration will build upon DiCE’s unique…
Read More...

Avista Pharma Solutions has completed extensive facility upgrades at its Longmont, Colorado site, expanding its drug product manufacturing footprint by approximately 20,000 square feet…
Read More...

BioLife Solutions announced that it has executed an agreement to supply its CryoStor cell freeze media and HypoThermosol cell storage and shipping media to Iovance Biotherapeutics.…
Read More...

Aratana Therapeutics, Inc. has received top-line pivotal field effectiveness study results for AT-016, an investigational adipose-derived allogeneic stem cell therapeutic candidate for…
Read More...

Teva Pharmaceutical Industries Ltd., announced the exclusive launch of generic Viread®1 (tenofovir disoproxil fumarate) tablets 300 mg in the U.S. Tenofovir disoproxil fumarate…
Read More...

Celltrion, Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending that Herzuma®…
Read More...

PixarBio Corporation developers of NeuroRelease NR14, a 14-day post-surgical pain treatment, announces an agreement between Particle Sciences (PSI), a Lubrizol Corporation Company, to…
Read More...

Regeneron Pharmaceuticals and ISA Pharmaceuticals announced a clinical collaboration to advance ISA101, an immunotherapy targeting human papillomavirus type 16 (HPV16)-induced cancer,…
Read More...

SSCI, part of AMRI’s Global Analytical Services, will expand its nuclear magnetic resonance (NMR) spectroscopy capabilities with the addition of the Bruker AVANCE NEO 600 MHz NMR…
Read More...

Renova Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the company's lead product candidate, RT-100 AC6 gene transfer…
Read More...